ArticleThe journal of allergy and clinical immunology. Global2025

Immune Development in Early Life (IDEaL) longitudinal cohort study protocol: Identifying biomarkers of vaccine responsiveness, respiratory infection, and asthma.

Donato Amodio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.